| UniProt ID | SUCB2_HUMAN | |
|---|---|---|
| UniProt AC | Q96I99 | |
| Protein Name | Succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03221} | |
| Gene Name | SUCLG2 {ECO:0000255|HAMAP-Rule:MF_03221} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 432 | |
| Subcellular Localization | Mitochondrion . | |
| Protein Description | GTP-specific succinyl-CoA synthetase functions in the citric acid cycle (TCA), coupling the hydrolysis of succinyl-CoA to the synthesis of GTP and thus represents the only step of substrate-level phosphorylation in the TCA. The beta subunit provides nucleotide specificity of the enzyme and binds the substrate succinate, while the binding sites for coenzyme A and phosphate are found in the alpha subunit.. | |
| Protein Sequence | MASPVAAQAGKLLRALALRPRFLAAGSQAVQLTSRRWLNLQEYQSKKLMSDNGVRVQRFFVADTANEALEAAKRLNAKEIVLKAQILAGGRGKGVFNSGLKGGVHLTKDPNVVGQLAKQMIGYNLATKQTPKEGVKVNKVMVAEALDISRETYLAILMDRSCNGPVLVGSPQGGVDIEEVAASNPELIFKEQIDIFEGIKDSQAQRMAENLGFVGPLKSQAADQITKLYNLFLKIDATQVEVNPFGETPEGQVVCFDAKINFDDNAEFRQKDIFAMDDKSENEPIENEAAKYDLKYIGLDGNIACFVNGAGLAMATCDIIFLNGGKPANFLDLGGGVKEAQVYQAFKLLTADPKVEAILVNIFGGIVNCAIIANGITKACRELELKVPLVVRLEGTNVQEAQKILNNSGLPITSAIDLEDAAKKAVASVAKK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 3 | Phosphorylation | -----MASPVAAQAG -----CCCHHHHHHH | 20.71 | - | |
| 47 | Malonylation | LQEYQSKKLMSDNGV HHHHHHHHHHHCCCC | 55.45 | 26320211 | |
| 73 | Acetylation | NEALEAAKRLNAKEI HHHHHHHHHCCHHHH | 65.55 | 19608861 | |
| 73 | Succinylation | NEALEAAKRLNAKEI HHHHHHHHHCCHHHH | 65.55 | 23954790 | |
| 73 | Malonylation | NEALEAAKRLNAKEI HHHHHHHHHCCHHHH | 65.55 | 26320211 | |
| 78 | Succinylation | AAKRLNAKEIVLKAQ HHHHCCHHHHHHHHH | 47.07 | - | |
| 78 | Succinylation | AAKRLNAKEIVLKAQ HHHHCCHHHHHHHHH | 47.07 | - | |
| 78 | Malonylation | AAKRLNAKEIVLKAQ HHHHCCHHHHHHHHH | 47.07 | 26320211 | |
| 93 | Malonylation | ILAGGRGKGVFNSGL HHHCCCCCCCCCCCC | 51.01 | 26320211 | |
| 101 | Malonylation | GVFNSGLKGGVHLTK CCCCCCCCCCEECCC | 58.08 | 26320211 | |
| 101 | Succinylation | GVFNSGLKGGVHLTK CCCCCCCCCCEECCC | 58.08 | 23954790 | |
| 108 | Acetylation | KGGVHLTKDPNVVGQ CCCEECCCCCCHHHH | 77.02 | 26051181 | |
| 108 | Malonylation | KGGVHLTKDPNVVGQ CCCEECCCCCCHHHH | 77.02 | 26320211 | |
| 118 | Ubiquitination | NVVGQLAKQMIGYNL CHHHHHHHHHHCCCC | 49.33 | 22817900 | |
| 118 | Ubiquitination | NVVGQLAKQMIGYNL CHHHHHHHHHHCCCC | 49.33 | 21890473 | |
| 132 | Sumoylation | LATKQTPKEGVKVNK CCCCCCCCCCCCCCE | 71.18 | - | |
| 132 | Sumoylation | LATKQTPKEGVKVNK CCCCCCCCCCCCCCE | 71.18 | - | |
| 132 | Acetylation | LATKQTPKEGVKVNK CCCCCCCCCCCCCCE | 71.18 | - | |
| 139 | Acetylation | KEGVKVNKVMVAEAL CCCCCCCEEEEEEHH | 34.39 | 26822725 | |
| 149 | Phosphorylation | VAEALDISRETYLAI EEEHHHCCHHHHHHH | 24.59 | 21406692 | |
| 152 | Phosphorylation | ALDISRETYLAILMD HHHCCHHHHHHHHHC | 23.79 | 22210691 | |
| 153 | Phosphorylation | LDISRETYLAILMDR HHCCHHHHHHHHHCC | 6.86 | 20068231 | |
| 161 | Phosphorylation | LAILMDRSCNGPVLV HHHHHCCCCCCCEEE | 13.99 | - | |
| 183 | Phosphorylation | DIEEVAASNPELIFK CHHHHHHHCHHHEEH | 43.08 | 22210691 | |
| 200 | Acetylation | IDIFEGIKDSQAQRM HHHHCCCCHHHHHHH | 63.28 | - | |
| 200 | Ubiquitination | IDIFEGIKDSQAQRM HHHHCCCCHHHHHHH | 63.28 | 29967540 | |
| 207 | Sulfoxidation | KDSQAQRMAENLGFV CHHHHHHHHHHCCCC | 3.49 | 28183972 | |
| 218 | Methylation | LGFVGPLKSQAADQI CCCCCCCHHHHHHHH | 43.59 | 66694157 | |
| 218 | Acetylation | LGFVGPLKSQAADQI CCCCCCCHHHHHHHH | 43.59 | 25953088 | |
| 218 | Malonylation | LGFVGPLKSQAADQI CCCCCCCHHHHHHHH | 43.59 | 26320211 | |
| 219 | Phosphorylation | GFVGPLKSQAADQIT CCCCCCHHHHHHHHH | 32.50 | 28102081 | |
| 226 | Phosphorylation | SQAADQITKLYNLFL HHHHHHHHHHHHHHH | 14.90 | 28102081 | |
| 227 | Acetylation | QAADQITKLYNLFLK HHHHHHHHHHHHHHC | 51.07 | 19608861 | |
| 229 | Phosphorylation | ADQITKLYNLFLKID HHHHHHHHHHHHCCC | 16.04 | 28152594 | |
| 255 | Glutathionylation | TPEGQVVCFDAKINF CCCCCEEEEECEECC | 2.41 | 22555962 | |
| 271 | Acetylation | DNAEFRQKDIFAMDD CCHHHHHHCEEEECC | 48.84 | 23236377 | |
| 271 | Succinylation | DNAEFRQKDIFAMDD CCHHHHHHCEEEECC | 48.84 | 27452117 | |
| 271 | Malonylation | DNAEFRQKDIFAMDD CCHHHHHHCEEEECC | 48.84 | 26320211 | |
| 279 | Acetylation | DIFAMDDKSENEPIE CEEEECCCCCCCCCC | 56.24 | 25038526 | |
| 280 | Phosphorylation | IFAMDDKSENEPIEN EEEECCCCCCCCCCC | 53.28 | 28857561 | |
| 291 | Acetylation | PIENEAAKYDLKYIG CCCCHHHHCCCEEEC | 46.47 | 19608861 | |
| 338 | Acetylation | LDLGGGVKEAQVYQA ECCCCCCHHHHHHHH | 51.08 | 23954790 | |
| 338 | Succinylation | LDLGGGVKEAQVYQA ECCCCCCHHHHHHHH | 51.08 | - | |
| 338 | Malonylation | LDLGGGVKEAQVYQA ECCCCCCHHHHHHHH | 51.08 | 26320211 | |
| 338 | Succinylation | LDLGGGVKEAQVYQA ECCCCCCHHHHHHHH | 51.08 | 27452117 | |
| 343 | Phosphorylation | GVKEAQVYQAFKLLT CCHHHHHHHHHHHHC | 5.09 | - | |
| 347 | Acetylation | AQVYQAFKLLTADPK HHHHHHHHHHCCCCC | 45.67 | 25953088 | |
| 386 | Ubiquitination | ACRELELKVPLVVRL HHHHHCCCCCEEEEE | 32.22 | 24816145 | |
| 386 | Acetylation | ACRELELKVPLVVRL HHHHHCCCCCEEEEE | 32.22 | - | |
| 403 | Acetylation | TNVQEAQKILNNSGL CCHHHHHHHHHCCCC | 57.09 | 23236377 | |
| 423 | Succinylation | IDLEDAAKKAVASVA CCHHHHHHHHHHHHH | 42.88 | 23954790 | |
| 423 | Acetylation | IDLEDAAKKAVASVA CCHHHHHHHHHHHHH | 42.88 | 25953088 | |
| 424 | Acetylation | DLEDAAKKAVASVAK CHHHHHHHHHHHHHC | 43.28 | 2391015 | |
| 431 | Acetylation | KAVASVAKK------ HHHHHHHCC------ | 57.78 | 2401413 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SUCB2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SUCB2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SUCB2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| OZF_HUMAN | ZNF146 | physical | 26186194 | |
| DJC12_HUMAN | DNAJC12 | physical | 26186194 | |
| GLT11_HUMAN | GALNT11 | physical | 26186194 | |
| ACADM_HUMAN | ACADM | physical | 26344197 | |
| VATA_HUMAN | ATP6V1A | physical | 26344197 | |
| TCPG_HUMAN | CCT3 | physical | 26344197 | |
| TCPZ_HUMAN | CCT6A | physical | 26344197 | |
| CATD_HUMAN | CTSD | physical | 26344197 | |
| ENPL_HUMAN | HSP90B1 | physical | 26344197 | |
| IDH3A_HUMAN | IDH3A | physical | 26344197 | |
| LDHA_HUMAN | LDHA | physical | 26344197 | |
| LDH6A_HUMAN | LDHAL6A | physical | 26344197 | |
| RPN1_HUMAN | RPN1 | physical | 26344197 | |
| SUCA_HUMAN | SUCLG1 | physical | 26344197 | |
| SUCA_HUMAN | SUCLG1 | physical | 28514442 | |
| GLT11_HUMAN | GALNT11 | physical | 28514442 | |
| OZF_HUMAN | ZNF146 | physical | 28514442 | |
| DJC12_HUMAN | DNAJC12 | physical | 28514442 | |
| ORNT1_HUMAN | SLC25A15 | physical | 28514442 |
| Kegg Disease | |
|---|---|
| There are no disease associations of PTM sites. | |
| OMIM Disease | |
| There are no disease associations of PTM sites. | |
| Kegg Drug | |
| There are no disease associations of PTM sites. | |
| DrugBank | |
| DB00139 | Succinic acid |
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-73; LYS-227; LYS-291 ANDLYS-338, AND MASS SPECTROMETRY. | |